Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Julia Goldner

Engagement Manager, Health & Life Sciences, Oliver Wyman

Access Will Become Commoditized

Providers’ strategic control and differentiation will shift to be based on experience, ease of use, and price.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

In light of breaking news, the pharma value chain is definitely ripe for disruption. Here's how health plans, employers, and drug companies can adjust to the new normal.

Partner, Health and Life Sciences, Oliver Wyman
Managing Partner, Americas, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman